Просмотр коллекции по группе - По тематике DRUG DESIGN

Перейти к: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
А Б В Г Д Е Ж З И Й К Л М Н О П Р С Т У Ф Х Ц Ч Ш Щ Ъ Ы Ь Э Ю Я
или введите несколько первых букв:  
Отображение результатов 1 до 8 из 8
Дата публикацииНазваниеАвторы
20226-(Tetrazol-5-yl)-7-aminoazolo[1,5-a]pyrimidines as Novel Potent CK2 InhibitorsUrakov, G. V.; Savateev, K. V.; Kotovskaya, S. K.; Rusinov, V. L.; Spasov, A. A.; Babkov, D. A.; Sokolova, E. V.
2022Benchmarking the ability of novel compounds to inhibit SARS-CoV-2 main protease using steered molecular dynamics simulationsSingh, R.; Bhardwaj, V. K.; Das, P.; Bhattacherjee, D.; Zyryanov, G. V.; Purohit, R.
2021Design and Antioxidant Properties of Bifunctional 2H-Imidazole-Derived Phenolic Compounds-A New Family of Effective Inhibitors for Oxidative Stress-Associated Destructive ProcessesGerasimova, E. L.; Gazizullina, E. R.; Borisova, M. V.; Igdisanova, D. I.; Nikiforov, E. A.; Moseev, T. D.; Varaksin, M. V.; Chupakhin, O. N.; Charushin, V. N.; Ivanova, A. V.
2020Fragment-based approach to novel bioactive purine derivativesKrasnov, V. P.; Levit, G. L.; Musiyak, V. V.; Gruzdev, D. A.; Charushin, V. N.
2016Improving treatment of neurodevelopmental disorders: Recommendations based on preclinical studiesHomberg, J. R.; Kyzar, E. J.; Stewart, A. M.; Nguyen, M.; Poudel, M. K.; Echevarria, D. J.; Collier, A. D.; Gaikwad, S.; Klimenko, V. M.; Norton, W.; Pittman, J.; Nakamura, S.; Koshiba, M.; Yamanouchi, H.; Apryatin, S. A.; Scattoni, M. L.; Diamond, D. M.; Ullmann, J. F. P.; Parker, M. O.; Brown, R. E.; Song, C.; Kalueff, A. V.
2020Novel pyranopyrazole derivatives comprising a benzoxazole core as antimicrobial inhibitors: Design, synthesis, microbial resistance and machine aided resultsReddy, G. M.; Kumari, A. K.; Reddy, V. H.; Garcia, J. R.
2018On a Generalized Levinthal's Paradox: The Role of Long- and Short Range Interactions in Complex Bio-molecular Reactions, Including Protein and DNA FoldingMelkikh, A. V.; Meijer, D. K. F.
2013(β-D-ribofuranosyl)formamidine in the design and synthesis of 2-(β-D-ribofuranosyl)pyrimidines, including RF-containing derivativesIaroshenko, V. O.; Dudkin, S.; Sosnovskikh, V. Y.; Villinger, A.; Langer, P.